Showing 1,841 - 1,860 results of 104,141 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( a ((fold decrease) OR (nn decrease)) ))', query time: 1.55s Refine Results
  1. 1841

    RelA–TA2 docks itself onto a series of interlinked hydrophobic grooves of TAZ1 through a number of hydrophobic residues, which serve as anchor points. by Sulakshana P. Mukherjee (453389)

    Published 2013
    “…The Leu449Ala and Leu465Ala mutants in RelA–TA2 lead to diminished association constants accompanied with decreased negative enthalpy change. …”
  2. 1842

    Illustration of MAD-FC transform and plot. by Bruce A. Corliss (8725967)

    Published 2024
    “…Column definitions for (<b>A</b>): |FCU|, absolute fold change units; Direction, whether fold change datapoint is negative/decreasing (–) or positive/increasing (+), or no change (NC); FC: fold change value; MFC, fold change value after mirror transform; MAD-FC, fold change value after mirror and contraction transform.…”
  3. 1843

    Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor by Beatrice Noce (16540800)

    Published 2025
    “…NADPH oxidases (NOXs) are enzymes dedicated to reactive oxygen species (ROS) production and are implicated in cancer, neuroinflammation, and neurodegenerative diseases. VAS2870 is a covalent inhibitor of mainly NOX2 and NOX5. It alkylates a conserved active-site cysteine, blocking productive substrate binding. …”
  4. 1844
  5. 1845

    Heatmap of fold-changes of metabolites. by Elena Heidenreich (6940475)

    Published 2019
    “…A) Metabolite fold-change per cell, B) Metabolite fold-change per POC.…”
  6. 1846
  7. 1847
  8. 1848
  9. 1849
  10. 1850
  11. 1851
  12. 1852
  13. 1853
  14. 1854
  15. 1855
  16. 1856
  17. 1857
  18. 1858
  19. 1859

    Decreased self-renewal capacity associated with senescence was prevented in human MSCs following treatment with Ki16425, an LPA<sub>1</sub>/LPA<sub>3</sub> antagonist. by Masahiko Kanehira (183764)

    Published 2012
    “…Human MSCs at passage 2 were cultured in the presence or absence of Ki16425 for the indicated days prior to cell lysis. Fold-change represents decrease in band intensity of Ki16425 treatment for 18 days compared with a control treatment for the same period of time. …”
  20. 1860